The Ecstasy and Related Drugs Reporting System (EDRS) is an illicit drug monitoring system which has been conducted in all states and territories of Australia since 2003, and forms part of Drug Trends

In 2022, we have provided a suite of products with the most up-to-date findings from interviews conducted annually from 2003 to 2022 with a cross-sectional sentinel group of people who regularly use ecstasy and other stimulants recruited from all capital cities of Australia. 

This includes: 

  1. A report overviewing the key findings in 2022; 
  2. Aninfographic summarising key findings in 2022; 
  3. A methodsdocument highlighting approaches to collating and presenting estimates; and 
  4. The executive summary, summarising key findings in 2022. 

Results are not representative of all consumers or drug use in the general population and should be interpreted alongside findings from other data sources for a more complete profile of emerging trends in illicit drug use in Australia. 

Latest release date 

21 September 2022  

Use of the data 

Please note that any presentation of these data should include acknowledgment of Drug Trends at the National Drug and Alcohol Research Centre, University of New South Wales. 

Citation:  Sutherland, R., Karlsson, A., King, C., Jones, F., Uporova, J., Price, O., Gibbs, D., Bruno, R., Dietze, P., Lenton, S., Salom, C., Grigg, J., Wilson, Y., Wilson, J., Daly, C., Thomas, N., Juckel, J., Degenhardt, L., Farrell, M. & Peacock, A. (2022). Australian Drug Trends 2022: Key Findings from the National Ecstasy and Related Drugs Reporting System (EDRS) Interviews. Sydney: National Drug and Alcohol Research Centre, UNSW Sydney. 


Drug Trends is supported by funding from the Australian Government Department of Health and Aged Care under the Drug and Alcohol Program. 


Please contact the research team at with any queries; to request additional analyses using these data; or to discuss the possibility of including items in future EDRS interviews. 



Rachel Sutherland, Antonia Karlsson, Cate King, Fiona Jones, Julia Uporova, Olivia Price, Daisy Gibbs, Raimondo Bruno, Paul Dietze, Simon Lenton, Caroline Salom, Jodie Grigg, Yalei Wilson, Joanna Wilson, Catherine Daly, Natalie Thomas, Jennifer Juckel, Louisa Degenhardt, Michael Farrell, Amy Peacock
Date Commenced
14 Sep 2022
Resource Type
Drug Trends National Reports